Cilazapril Monohydrate structure
|
Common Name | Cilazapril Monohydrate | ||
---|---|---|---|---|
CAS Number | 92077-78-6 | Molecular Weight | 435.51400 | |
Density | N/A | Boiling Point | 598.1ºC at 760mmHg | |
Molecular Formula | C22H33N3O6 | Melting Point | 98° (dec) | |
MSDS | N/A | Flash Point | 315.5ºC |
Use of Cilazapril MonohydrateCilazapril Monohydrate is a angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.Target: ACECilazapril is a new nonthiol group containing angiotensin converting enzyme (ACE) inhibitor. Cilazapril has been investigated in more than 4000 patients with all degrees of hypertension, as well as in the special patient groups such as the elderly, renally impaired, and patients with concomitant diseases, such as congestive cardiac failure or chronic obstructive pulmonary disease [1]. Cilazapril is a very potent and highly effective converting enzyme inhibitor. Doses well below 5 mg/day will probably suffice for therapeutic efficacy [2]. |
Name | cilazapril |
---|---|
Synonym | More Synonyms |
Description | Cilazapril Monohydrate is a angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.Target: ACECilazapril is a new nonthiol group containing angiotensin converting enzyme (ACE) inhibitor. Cilazapril has been investigated in more than 4000 patients with all degrees of hypertension, as well as in the special patient groups such as the elderly, renally impaired, and patients with concomitant diseases, such as congestive cardiac failure or chronic obstructive pulmonary disease [1]. Cilazapril is a very potent and highly effective converting enzyme inhibitor. Doses well below 5 mg/day will probably suffice for therapeutic efficacy [2]. |
---|---|
Related Catalog | |
References |
[1]. Szucs, T., Cilazapril. A review. Drugs, 1991. 41 Suppl 1: p. 18-24. |
Boiling Point | 598.1ºC at 760mmHg |
---|---|
Melting Point | 98° (dec) |
Molecular Formula | C22H33N3O6 |
Molecular Weight | 435.51400 |
Flash Point | 315.5ºC |
Exact Mass | 435.23700 |
PSA | 108.41000 |
LogP | 1.79790 |
Storage condition | -20℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Cilazapril stability in the presence of hydrochlorothiazide in model mixtures and fixed dose combination.
Acta Pol. Pharm. 70(6) , 1079-85, (2013) The presented study aimed at the evaluation of hydrochlorothiazide influence on cilazapril stability in model mixture and fixed dose tablet formulation. The degradation of cilazapril in the presence o... |
|
Common medications among dental outpatients: considerations in general dental practice.
N. Z. Dent. J. 108(4) , 140-7, (2012) To provide information about the most common medications listed as being taken by dental patients presenting to an outpatient setting at a tertiary institution and to establish a list of the most comm... |
|
Ultra-thin-layer chromatography mass spectrometry and thin-layer chromatography mass spectrometry of single peptides of angiotensin-converting enzyme inhibitors.
J. Chromatogr. A. 1218(20) , 3089-94, (2011) The separation of structurally related angiotensin-converting enzyme (ACE) inhibitors lisinopril, cilazapril, ramipril and quinapril and their corresponding active diacid forms (prilates) by conventio... |
Cilazapril Monohydrate |
Cilazapril (monohydrate) |